Media hits this week from Professors Lefstin and Zitrin, and other scholarly activities from Joan Williams, Robin Feldman and Dean Wu.
Professor Jeffrey Lefstin has written extensively about the Supreme Court’s ruling in Myriad. Though that case is over, the debate on patents in biotechnology is just heating up. "The Supreme Court's effort to stop specific companies from monopolizing laws of nature seems at odds with the concept of a patent," Lefstin said. "A patent, by definition, always creates a monopoly. It's been perceived as part of the bargain of the patent system."
An expert on legal ethics, Professor Richard Zitrin is quoted extensively in this Law.com article about automatic disbarment for particular offenses. "I don't agree, in general, with per se disbarment rules," says Richard Zitrin. "They afford no discretion. Rules that don't allow discretion - particularly judicial discretion - tend to be not good rules."
Patent troll expert Robin Feldman will testify before the Assembly Select Committee on High Technology at an informational hearing convened by Assemblymember Paul Fong on Patent Assertion Entities Wednesday, October 30, 2013 at Google Headquarters in Mountain View.
Professor Joan C. Williams pens an Op/Ed for the blog of the Harvard Business Review. Her work is also cited by the Daily Beast and Genetic Engineering & Biotechnology News.
Finally, a new blog has been launched by three law deans – one of their first entries was a re-post of Chancellor & Dean Frank H. Wu’s previous blogpost on the Huffington Post. The new law dean's blog caught the attention of Law.com's Karen Sloane, who quoted Dean Wu in her reporting about the launch.